Wet AMD 5 Symposium

Related

• 

  Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD

  Peter A. Campochiaro, MD

  Updates from the Field

  2020

• 

  Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated With Intravitreal Aflibercept or Ranibizumab in the VIEW studies

  Robert L. Avery, MD

  On Demand Cases, Courses, and Papers

  2017

• 

  Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema

  Chirag D. Jhaveri, MD, FASRS

  Updates from the Field

  2022